Dr. Mamedova Leyla
ActiveSummary
Dr. Mamedova Leyla has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €59,251 and a net result of €56,751. The computed 12-month bankruptcy probability is 0.7% (low).
Overview
Official details
Source: KBO- Status
- Active since 10-06-2025 Normal situation
- Activity
- “De uitoefening van de geneeskunde, meer bepaald de huisartskunde, door de arts-aandeelhouder, met inachtneming…” (deed in Dutch)From the articles, 10 activitiesNo NACE code in the KBO yet
- Establishment units
- 2.375.824.265 2040 Antwerpen, since 10-06-2025
- 2.375.824.364 2060 Antwerpen, since 10-06-2025
- Financial year end
- 31 December
- Peppol
- Reachable since 18-02-2026
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.7%
- Gross margin
- €80,138
- Turnover
- ≈ €240,000
- estimated
- Profit
- €56,751
- Equity
- €59,251
- Total assets
- €59,536
- 2025 accounts filed 61 days after the deadline
Score breakdownraises riskNo main activity registeredLast filed accounts filed 61 days late; 1 of the last 3 accounts lateFounded in 2025lowers riskLiquidity: current ratio 203.72, cash €54,016Show the evidence
Checked score
About 7 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 81% of them on solvency, 95% on liquidity and 90% on profitability.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Searched, nothing found (1)
Recent changes
- · Gazette deed IncorporationStarting capital €2,500 · Appointment: MAMEDOVA Leyla Muzaffarovna (director)
Key facts about Dr. Mamedova Leyla
- What is the company number of Dr. Mamedova Leyla?
- The company number of Dr. Mamedova Leyla is 1024.156.088. The VAT number is the same number with BE in front: BE 1024.156.088.
- Where is Dr. Mamedova Leyla based?
- The registered office is at Norbertijnenstraat 3, 2040 Antwerpen.Company details
- What is the legal form of Dr. Mamedova Leyla?
- The legal form of Dr. Mamedova Leyla is Private limited company (BV).
- When was Dr. Mamedova Leyla founded?
- Dr. Mamedova Leyla was founded on 10-06-2025.
- Is Dr. Mamedova Leyla still active?
- Yes, Dr. Mamedova Leyla is an active enterprise in the KBO register.
- What is the turnover of Dr. Mamedova Leyla?
- The turnover in financial year 2025 is ≈ €240,000. This figure is estimated from the gross margin of €80,138 and 2,672 comparable companies of the same size. It probably lies between €160,000 and €420,000. It is a rough estimate.Financials
- Is Dr. Mamedova Leyla profitable?
- In financial year 2025, Dr. Mamedova Leyla made a profit of €56,751.
- Where can I find the annual accounts of Dr. Mamedova Leyla?
- Dr. Mamedova Leyla filed 1 annual account with the National Bank of Belgium, for financial year 2025.
Next steps
See how customers, suppliers and banks see your own company and what to improve first.